Man Group’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q2 | – | Sell |
-771,934
| Closed | -$3.5M | – | 1861 |
|
2024
Q1 | $3.5M | Buy |
+771,934
| New | +$3.5M | 0.01% | 1025 |
|
2023
Q1 | – | Sell |
-305,478
| Closed | -$3.09M | – | 2002 |
|
2022
Q4 | $3.09M | Sell |
305,478
-359,944
| -54% | -$3.65M | 0.01% | 1008 |
|
2022
Q3 | $6.58M | Buy |
+665,422
| New | +$6.58M | 0.03% | 632 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 1112 |
|
2021
Q4 | – | Sell |
-49,165
| Closed | -$985K | – | 1855 |
|
2021
Q3 | $985K | Buy |
49,165
+3,308
| +7% | +$66.3K | ﹤0.01% | 1333 |
|
2021
Q2 | $1.01M | Buy |
45,857
+552
| +1% | +$12.1K | ﹤0.01% | 1388 |
|
2021
Q1 | $1.54M | Buy |
+45,305
| New | +$1.54M | 0.01% | 1183 |
|